Skip to main content
. 2014 Mar 11;3:69. [Version 1] doi: 10.12688/f1000research.3713.1

Table 1. Data sets and programs.

Entry Year Subject area
index label
Description
1 [9] 2007 VS_ML_1 9 activity classes (AC) with increasing structural diversity
2 [9] 2007 VS_ML_2 ~1.44 million ZINC compounds used for various virtual screening trials
3 [10] 2007 PROG_1 Molecular similarity histogram filtering
4 [11] 2007 SSR_1 4 SD files with 26 selectivity sets; compounds are annotated with selectivity values for different targets
5 [12] 2008 SSR_2 7 compound selectivity sets containing 267 biogenic amine GPCR antagonists
6 [13] 2008 SSR_3 18 selectivity sets for targets from 4 families
7 [14] 2008 VS_ML_3 25 sets of compounds of increasing complexity and size
8 [15] 2009 VS_ML_4 242 hERG inhibitors
9 [16] 2009 SSR_4 243 ionotropic glutamate ion channel antagonists
10 [17] 2009 PROG_2 Combinatorial analog graph (CAG) program with a sample set consisting of 51 thrombin inhibitors
11 [18] 2009 VS_ML_5 20 AC from the literature and 15 AC from the Molecular Drug Data Report
12 [19] 2010 VS_ML_6 8 AC
13 [20] 2010 PROG_3 Program to generate target selectivity patterns of scaffolds
14 [21] 2010 PROG_4 Multi-target CAGs (see also entry 10) with a sample set containing 33 kinase inhibitors
15 [22] 2010 PROG_5 SARANEA
16 [23] 2010 PROG_6 3D activity landscape program with a sample set containing 248 cathepsin S inhibitors
17 [24] 2010 SAR_1 2 sets of MMPs from BindingDB and ChEMBL
18 [25] 2010 PROG_7 Similarity-potency tree (SPT) program with a sample set containing 874 factor Xa inhibitors
19 [26] 2010 VS_ML_7 17 target-directed compound sets; each set contains a minimum of 10 distinct scaffolds and each
scaffold represents 5 compounds
20 [27] 2011 SAR_VZ 10,489 malaria screening hits
21 [28] 2011 SAR_2 458 target-based sets with scaffolds and scaffold hierarchies
22 [29] 2011 SAR_VZ 4 sets of compounds active against 3 or 4 targets
23 [30] 2011 SAR_VZ 881 factor Xa inhibitors
24 [31] 2011 VS_ML_8 50 AC prioritized for similarity searching
25 [32] 2011 VS_ML_9 25 data sets from successful ligand-based virtual screening applications
26 [33] 2011 SAR_3 26 conserved scaffolds in activity profile sequences of length 4
27 [34] 2011 PROG_8 Scaffold distance function
28 [35] 2011 SAR_4 2 sets of compounds with multiple K i or IC 50 measurements against the same targets that differed within
1 order of magnitude
29 [36] 2012 SAR_VZ 4 AC
30 [37] 2012 SAR_5 5 sets of different types of activity cliffs
31 [38] 2012 VS_ML_10 50 AC for scaffold hopping analysis
32 [39] 2012 SAR_6 61 AC consisting of SAR transfer series with regular potency progression
33 [40] 2013 SAR_7 4 activity measurement type-dependent sets of scaffolds
34 [41] 2013 VS_ML_11 2 multi-target compound sets
35 [42] 2013 VS_ML_12 4 multi-target compound sets and 3 multi-mechanism sets
36 [43] 2013 SAR_8 2337 compound series matrices
37 [44] 2013 SAR_9 128 AC containing ≥100 compounds with K i values
38 [45] 2014 SAR_10 30,452 and 45,607 target-based MMS with K i and IC 50 values, respectively
39 [46] 2014 SAR_11 221 drug-unique scaffolds
40 [47] 2014 SAR_12 92,734 MMPs based upon retrosynthetic rules for 435 AC
41 [8] 2014 SAR_13 20,073 and 25,297 MMP-based activity cliffs with K i and IC 50 values, respectively
42 [8] 2014 SAR_14 4 activity measurement type-dependent sets of SAR transfer series with approximate or regular
potency progression
43 [8] 2014 SAR_15 169,889 and 240,322 transformation size-restricted MMPs based upon retrosynthetic rules with K i and
IC 50 values, respectively

Data entries are organized according to scientific subject areas: structure-activity relationship (SAR) and structure-selectivity relationship (SSR) analysis, SAR visualization (SAR_VZ), virtual screening via similarity searching or machine learning (VS_ML), and programs (PROG). References in the Entry column provide the original publication introducing the program and/or data set. Program entries are described in more detail in Table 2 of our original data article 1. The new compound data sets 31–43 are discussed in the text. Programs and data sets reported herein have been separately deposited in ZENODO for access and download.